In conclusion, our study reveals that KDM1A aggravates liver steatosis and inflammation through increasing the accessibility of chromatin, demonstrating that harnessing chromatin remodeling and epigenetic modifications is crucial for managing NAFLD. Here, KDM1A is linked to fatty liver disease.